Scientists track rare brain disease in children to find clues for future treatments
NCT ID NCT05659901
Summary
This study aims to understand how Pelizaeus-Merzbacher disease (PMD) progresses over time in boys aged 6 months to 17 years. Researchers will collect spinal fluid, blood samples, and brain scans to identify biological markers that change as the disease advances. The information gathered will help guide the development of future therapies for this rare genetic brain disorder.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELIZAEUS-MERZBACHER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ionis Investigative Site
RECRUITINGAtlanta, Georgia, 30342, United States
-
Ionis Investigative Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Ionis Investigative Site
RECRUITINGClermont-Ferrand, France
-
Ionis Investigative Site
RECRUITINGLe Kremlin-Bicêtre, 94270, France
-
Ionis Investigative Site
ACTIVE_NOT_RECRUITINGGöttingen, Germany
-
Ionis Investigative Site
RECRUITINGTel Aviv, 6423906, Israel
-
Ionis Investigative Site
RECRUITINGMilan, 20154, Italy
-
Ionis Investigative Site
RECRUITINGAmsterdam, 1081 HV, Netherlands
Conditions
Explore the condition pages connected to this study.